16:20 EST Eli Lilly (LLY) to acquire Ventyx Biosciences (VTYX) for $14.00 per share cash
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- InduPro Therapeutics announces strategic collaboration with Eli Lilly
- Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
- Lilly’s New Phase 3 Obesity Trial Signals Long-Term Upside in Weight-Loss Market
- Eli Lilly Stock (LLY) Has 50% Upside, Says Citigroup
- LLY, JNJ, PFE: Big Pharma’s 2025 Comeback Is Bigger Than the Obesity Craze